FGF2 and breast cancer: Fibroblast cells, MCF7, T47D, MDA-MB-231, BJ, and IMR90, were used to study the involvement of ECM in estrogen signaling by interacting with bFGF in ER-positive breast cancer cells via the signaling pathway of Erk1/2 [201,202].